Daily Update | August 7, 2026
Executive Summary
• DRC’s Ebola (Bundibugyo virus) outbreak is now the second-deadliest Ebola outbreak in history (4,053 cases / 1,850 deaths, ~44% CFR) and is outpacing containment efforts — WHO and Africa CDC leadership visited the region Aug 5–6 to urge an urgent scale-up. It remains a WHO Public Health Emergency of International Concern (declared May 17, 2026).
• US measles activity continues to climb (2,371 cases in 2026, 94% outbreak-associated), with a new outbreak just declared in Delaware; falling MMR coverage (92.5% among kindergartners) is the underlying driver.
• Avian influenza continues to diversify and spread geographically: new human H9N2 cases in China, a reported H5N1 case in an infant in Cambodia (unconfirmed detail), continued US dairy-cattle/poultry H5N1 activity, and Australia’s first-ever H5N1 detection in wild birds.
Pathogen-by-Pathogen Briefing
1. SARS-CoV-2 / COVID-19
Status: No major update today. ECDC’s most recent detailed regional assessment (May 29, 2026) describes ongoing endemic circulation with no acute signal; COVID is now managed through routine respiratory-virus surveillance alongside flu and RSV.
• Recent literature coverage has focused on updated vaccine effectiveness (2025–26 boosters reduced urgent-care visits by ~50% and symptomatic disease by 59%) and long-COVID sequelae rather than new outbreak activity.
• No specific dominant-variant name could be confirmed from available sources as of this briefing — flagged as a data gap, not an assumption.
Severity: Low
Trend: Stable
Why it matters now: Baseline surveillance shows no emerging variant-of-concern signal, but the Northern Hemisphere summer reporting lull limits visibility; re-check as autumn surveillance ramps up.
2. Measles
Status: US measles activity remains substantially elevated. CDC reports 2,371 confirmed cases in 2026 as of July 30 (2,355 domestic + 16 among international travelers), across 45 jurisdictions, with 37 outbreaks declared and 94% of cases outbreak-associated.
• Delaware just declared its first outbreak in over a decade (4 cases) after an unvaccinated Kent County resident tested positive.
• CIDRAP coverage referenced a UK measles death; case details/date could not be independently verified and are flagged as unconfirmed.
Severity: High
Trend: Worsening
Why it matters now: Kindergarten MMR coverage has fallen to 92.5% nationally — below the 95% herd-immunity threshold — leaving an estimated 286,000 young US children vulnerable. New states reporting first outbreaks in years signals continued geographic spread rather than containment.
3. Diphtheria
Status: No major update today. Background: ECDC’s most recent formal risk assessment (July 2025) documented the C. diphtheriae ST574 strain circulating in at least five EU/EEA countries plus Switzerland (82 cases, 2023–2025), concentrated among homeless populations, people who use drugs, and unvaccinated/older adults.
• General-population risk in highly vaccinated countries remains “very low.” No newer authoritative update was found.
Severity: Low
Trend: Stable
Why it matters now: Persistent low-level circulation in vulnerable populations, combined with reported global diphtheria antitoxin shortages, keeps this on the monitoring list even without new acute activity.
4. Avian Flu (H5N1 / H9N2 / other H*N*)
Status: Multiple concurrent threads are active across several countries:
• H9N2 (China): WHO reported 3 new human cases (July 10–16, 2026) — two 4-year-old boys (recovered) and a 44-year-old man (hospitalized in ICU at last report). China has recorded 170 of 173 human H9N2 infections documented globally since 2015 (2 deaths cumulative).
• H5N1 (Cambodia): A case reported in an infant per headline coverage; additional case details or an exact date could not be confirmed from a primary source — flagged as preliminary.
• H5N1 (United States): Continued detections in dairy cattle (Idaho, ~54 herd-level cases YTD) and egg-laying poultry (Utah). Cumulative US human H5 cases since Feb 2024: 71, almost entirely among dairy/poultry workers with direct animal exposure. CDC assesses general public health risk as low.
• H5N1 (Australia): First-ever detection in wild birds on a continent that had remained H5N1-free — a notable geographic milestone.
Severity: Moderate
Trend: Worsening (geographic spread) / Unclear (human severity)
Why it matters now: Continued mammalian spillover, an ICU-level human H9N2 case, and H5N1’s arrival in a previously unaffected continent all raise the reassortment/adaptation watch level, even though population-level risk assessments remain “low” for now.
5. Pertussis (Whooping Cough)
Status: No major new development dated to today, but the underlying trend remains notable. The US recorded 28,783 confirmed/probable cases in the most recently completed full year — the highest in the Americas region — and 2025 case counts (>25,000) marked a second consecutive high-activity year, including three infant deaths in Kentucky.
• PAHO has warned of a region-wide first-dose vaccination coverage gap (87%, down from pre-pandemic levels).
Severity: Moderate
Trend: Stable-to-elevated (multi-year resurgence)
Why it matters now: Sustained above-baseline circulation with vaccination gaps in the pediatric/maternal population increases risk of infant morbidity and mortality; maternal Tdap vaccination cuts infant hospitalization/ED visits by 70–89% where uptake is adequate.
6. Ebola (Bundibugyo virus disease — DRC / Uganda)
Status: This is the most significant global event in today’s briefing.
• Declared a WHO Public Health Emergency of International Concern on May 17, 2026.
• 4,053 confirmed cases and 1,850 deaths as of the most recent WHO/Africa CDC reporting (early August 2026) — the second-deadliest Ebola outbreak in history and the largest ever recorded in DRC. Crude case-fatality rate is running roughly 44%.
• Ituri province accounts for the large majority of cases and deaths (estimates range 88–90% across recent reports); the outbreak is adding ~75 new cases per day on average.
• Africa CDC Director-General Jean Kaseya reported that more than 70% of new cases and 67% of deaths are now originating in the community rather than from traced contacts — a strong signal that transmission is outpacing contact-tracing capacity.
• WHO Director-General Tedros Adhanom Ghebreyesus and Kaseya visited affected areas Aug 5–6, 2026 to press for a substantial scale-up of the response; Kaseya has publicly stated there is “no magical solution.”
• Healthcare-worker cases are significant (151 cases, 44 deaths, ~29% CFR among responders).
• Secondary impact: rising maternal mortality (an estimated six women per week dying of childbirth complications as women avoid facilities), compounded by reported aid cuts that have reduced sanitation-funding capacity by more than half between 2024 and 2025.
• Uganda’s linked, smaller outbreak has been declared over (20 cases, 2 deaths).
• Vaccines: WHO recommends prioritizing the licensed Ervebo vaccine in a phase 3 trial for this strain; Bundibugyo-specific candidates from Moderna and Oxford Vaccine Group have entered phase 1 trials; preliminary research suggests existing vaccine stockpiles may generate some cross-reactive antibody response.
Severity: High
Trend: Worsening
Why it matters now: This is a PHEIC-level event with a historically high case count, a rising share of untraceable community transmission, and compounding health-system and humanitarian-funding pressures. It warrants top-line attention for cross-border spread risk, vaccine/therapeutic deployment decisions, and international response coordination.
7. RSV
Status: No major update today. The Northern Hemisphere is in its off-season lull; CDC surveillance confirms circulation has returned to pre-pandemic seasonal patterns but shows no current elevated-activity signal.
• Maternal RSV vaccination during pregnancy has been associated with a ~70% reduction in infant hospitalizations.
• A separate study found a 36% lower risk of invasive pneumococcal disease among RSV-immunized newborns.
Severity: Low
Trend: Stable (seasonal lull)
Why it matters now: These vaccine-effectiveness findings are useful ahead of the fall/winter RSV season ramp-up and maternal-vaccination counseling.
8. Influenza A
Status: No major update today, and current-week strain-level surveillance data could not be confirmed from accessible sources — flagged as a data gap rather than an assumption of no activity. The Northern Hemisphere is in its typical summer seasonal lull.
• 2025–26 season context: 149 pediatric flu deaths were reported, the large majority in unvaccinated children; some analyses suggested influenza posed a greater hospitalization risk than COVID-19 last winter.
• The first mRNA-platform flu vaccine received FDA approval, which may improve vaccine effectiveness in future seasons.
Severity: Low (seasonal lull); vaccine news is Moderate-relevance
Trend: Unclear (insufficient current surveillance data accessed)
Why it matters now: The mRNA flu vaccine approval is a meaningful vaccination-implications development to track ahead of Southern Hemisphere season close-out and Northern Hemisphere fall planning.
9. Influenza B
Status: No major update today. Northern Hemisphere activity remains in its seasonal lull; no current elevated-activity signal identified.
Severity: Low
Trend: Stable
Why it matters now: Low absolute burden currently, but B-lineage predominance patterns remain relevant to Southern Hemisphere surveillance and planning for the next Northern Hemisphere season.
Other Outbreaks of Interest
Cyclospora (multistate US, foodborne parasitic illness)
• At least two concurrent outbreak threads are active. Michigan alone has confirmed over 2,600 cyclosporiasis cases, with the outbreak reported to have expanded to at least 9 states (including Illinois, Kansas, Oklahoma, and Pennsylvania).
• A separate, unrelated multistate outbreak has been linked to iceberg lettuce from Mexican suppliers served at Taco Bell locations in 5 states.
• Headline coverage referenced deaths in the Michigan cluster; an exact death count could not be independently confirmed from a primary source — flagged as preliminary.
Severity: Moderate
Trend: Improving in Michigan specifically (“worst is behind us” per state officials) but still expanding nationally overall.
Cholera (sub-Saharan Africa)
• Recent (non-dated-to-today) coverage indicates Sudan’s 18-month outbreak has ended (cumulative >100,000 cases, ~2,408 deaths), while DR Congo, Chad, and the Republic of Congo have reported ongoing/rising case counts (DRC cited at roughly 58,000 cases and 1,700 deaths over a recent 9-month period).
• Could not confirm whether these figures reflect August 2026 conditions specifically — included as background regional context; recommend independent verification via WHO AFRO or Africa CDC before decision-use.
US public health leadership
• The US Senate has confirmed a new CDC Director — an organizational/response-capacity development rather than a disease signal, noted here given its relevance to future US outbreak-response coordination.
Watchlist (Pathogens to Monitor Closely)
★ SARS-CoV-2 — standing watchlist item; monitor for autumn variant signal
★ Measles — standing watchlist item; US trajectory still climbing, new states affected
★ Ebola (DRC/Uganda, Bundibugyo virus) — active PHEIC, worsening trajectory, outpacing response capacity
★ Avian influenza (H5N1/H9N2) — geographic spread (Australia) and severe human H9N2 case; mammalian spillover continuing in US
★ Pertussis — multi-year US/Americas resurgence with vaccination coverage gaps
★ Cyclospora (US, multistate foodborne) — active, evolving, healthcare and public-communication impact
References
• WHO Disease Outbreak News (archive/index)
• WHO Ebola disease fact sheet
• CDC bird flu (H5) situation summary
• ECDC rapid risk assessment, diphtheria ST574 (EU/EEA), Jul 8 2025
• ECDC COVID-19 page (communicable disease threats report, week 22, 2026)
• CIDRAP — Ebola outbreak now second-deadliest in history
• CIDRAP — WHO/Africa CDC urge scale-up of Ebola response (Aug 6, 2026)
• CIDRAP — Ebola outbreak outpaces response efforts
• CIDRAP — Africa CDC chief “no magical solution”
• CIDRAP — Ebola deaths top 1,000 / measles Delaware / H9N2 China
• CIDRAP — avian influenza/bird flu topic page
• CIDRAP — cholera topic coverage
• CIDRAP — pertussis/whooping cough coverage
• CIDRAP — homepage / top headlines
Watch Items for Next Briefing
1. DRC/Uganda Ebola: updated case/death counts, whether community-transmission share continues rising, and any cross-border spread beyond Uganda.
2. Ebola vaccine trial progress (Ervebo phase 3; Moderna/Oxford Bundibugyo-specific candidates) and any stockpile deployment decisions.
3. US measles: whether Delaware’s outbreak grows beyond 4 cases and whether any additional states report first-in-years outbreaks.
4. Avian flu: confirmation/details on the reported Cambodia H5N1 infant case; status of the hospitalized H9N2 adult patient in China; any further H5N1 spread within Australia.
5. Verification of the reported UK measles death (details currently unconfirmed).
6. Cyclospora: updated multistate case counts and confirmed death toll, and resolution status of the two concurrent US outbreak threads.
7. Confirm current-week influenza A/B and RSV surveillance data once accessible, ahead of Southern Hemisphere season close-out.
Keep up your kindness and hopefully help someone with Long Covid or prevent it by encouraging masking, boosting, and clean air!
Take care,
Joe
I should be wearing a mask for my emoji on X, but I was in the middle of a lake when I took this.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.